Advaxis

From WikiMD.com - Food, Medicine & Wellness Encyclopedia

Advaxis[edit | edit source]

Advaxis logo

Advaxis is a biotechnology company focused on the development of cancer immunotherapies. The company utilizes Listeria monocytogenes-based antigen delivery technology to stimulate the immune system to target and destroy cancer cells. This approach is designed to enhance the body's natural defenses against cancer by using live, attenuated bacteria to deliver tumor-specific antigens directly to the immune system.

Technology[edit | edit source]

Advaxis's core technology platform is based on the use of Listeria monocytogenes, a type of bacteria that can stimulate a strong immune response. The company engineers these bacteria to express tumor-associated antigens, which are proteins found on the surface of cancer cells. When introduced into the body, these engineered bacteria are taken up by antigen-presenting cells, which then present the antigens to T cells, a type of white blood cell that plays a critical role in the immune response.

The activation of T cells leads to the targeting and destruction of cancer cells that express the specific antigens. This method aims to create a robust and targeted immune response against tumors, potentially leading to improved outcomes for patients with various types of cancer.

Clinical Development[edit | edit source]

Advaxis has several product candidates in various stages of clinical development. These include therapies for cervical cancer, head and neck cancer, and other solid tumors. The company's lead product candidate, ADXS-HPV, is designed to treat human papillomavirus (HPV)-associated cancers by targeting the E7 protein, a viral oncoprotein expressed in these cancers.

The company is also exploring combination therapies that pair its Listeria-based immunotherapies with other treatments, such as checkpoint inhibitors, to enhance the overall effectiveness of cancer treatment.

Partnerships and Collaborations[edit | edit source]

Advaxis has established partnerships with several pharmaceutical companies and research institutions to advance its pipeline of immunotherapies. These collaborations aim to leverage complementary technologies and expertise to accelerate the development and commercialization of new cancer treatments.

Challenges and Future Directions[edit | edit source]

While Advaxis's technology holds promise, the company faces challenges common to the biotechnology industry, including regulatory hurdles, competition from other immunotherapy approaches, and the need for extensive clinical testing to demonstrate safety and efficacy.

Looking forward, Advaxis aims to expand its pipeline, explore new indications, and continue to refine its technology to improve patient outcomes. The company is committed to advancing the field of cancer immunotherapy and providing new treatment options for patients with unmet medical needs.

Related pages[edit | edit source]

WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Transform your life with W8MD's budget GLP1 injections from $125 and up biweekly

W8mdlogo.png
W8MD weight loss doctors team

W8MD offers a medical weight loss program NYC and a clinic to lose weight in Philadelphia. Our W8MD's physician supervised medical weight loss centers in NYC provides expert medical guidance, and offers telemedicine options for convenience.

Why choose W8MD?

Book Your Appointment

Start your NYC weight loss journey today at our NYC medical weight loss, and Philadelphia and visit Philadelphia medical weight loss Call (718)946-5500 for NY and 215 676 2334 for PA

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's NYC physician weight loss.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available. Call 718 946 5500.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD